Ibrahim Qaddoumi, MD, MS (Pediatric Oncology)

In Oncology, my research focuses primarily on low-grade gliomas (LGGs), particularly the aggressive subtypes. One facet of my research program centers on studying novel molecular-targeted therapies to avoid the many chemotherapy regimens that children with LGG require because of multiple recurrences. Another aspect of my research program focuses on improving the quality-of-life (QoL) of patients with LGG. Maintaining a relatively high QoL is important for survivors of LGG because of the generally excellent long-term survival rates for children with LGG. Another important approach to improving quality of life in LGG is by decreasing the diagnostic interval and this can be done through research and education. I am working on an educational initiative that will be implemented at a global level. This will help decrease delayed diagnosis in children with CNS tumors. VSports app下载.

Approximately 85% of children with cancer reside in developing countries. Another important aspect of my research program is improving the care for this underserved population through a global approach V体育官网. Integrating telemedicine in these efforts has helped many children around the world, as documented through work by the Global Pediatric Medicine (GPM) department at St. Jude in Central America and the Middle East. In addition to decreasing morbidity and mortality for patients with LGG in developing countries through telemedicine-based initiatives, the potential for increasing research efforts in the developed world is evident, as shown through a GPM initiative undertaken for children with osteosarcoma in Chile. In addition, cancer centers in developing countries can support biologic and genetic research by providing tumor tissues for molecular analyses in pediatric cancer studies. One of my main strengths is building programs and I plan to apply this skill in different countries to help build local capacity to treat brain tumors and retinoblastoma at a global level.

Editorial Board (Pediatrics)
Terms of Appointment: June 2020 - December 2021

Associate Editor-in-Chief
Terms of Appointment: January 2022 - December 2023;  January 2024 - December 2025